Search - tctmd.com

Displaying 441 - 460 of 555

Sort: Relevancy | Date

News Conference News THT 2023

TEER or VAD/Transplant in the Advanced HF Patient With MR?

Shelley Wood

March 20, 2023

News Conference News THT 2023

PCI’s Role for Patients With HFrEF and Extensive CAD: Experts Debate

Todd Neale

March 20, 2023

Presentation THT 2023

What are the Strengths and Limitations of a Two-Phase (6-Month Intermediate Endpoints & 12-18 Month Mortality and Heart Failure Hospitalization) Trial Design

Presenter: William Abraham

March 20, 2023

News Daily News

Small Improvements in Fitness Add Up to Big Mortality Gains, Study Finds

L.A. McKeown

March 20, 2023

News Daily News

Second Recall in Less Than 2 Months for Cardiosave IABPs

L.A. McKeown

March 17, 2023

News Daily News

SAFE-AAA Flags Ongoing EVAR Device Risk and Urges More Surveillance

L.A. McKeown

March 16, 2023

News Daily News

Acute AF Can Recur: Manage and Monitor Long-term, Says AHA

Michael O'Riordan

March 16, 2023

News Daily News

Sugar Substitute Erythritol Linked to Cardiac Risk

Yael L. Maxwell

March 15, 2023

News Daily News

Mediterranean Diet’s CV Benefits Extend to Women: Meta-analysis

Caitlin E. Cox

March 15, 2023

News Conference News ACC 2023

Diabetic Patients in Middle East, Africa Overburdened by ASCVD

Michael O'Riordan

March 14, 2023

News Conference News ACC 2023

IMPLEMENT-HF: ‘Virtual’ Stewardship May Help Optimize GDMT in HFrEF

L.A. McKeown

March 14, 2023

News Conference News ACC 2023

CRP More Predictive of Future Events Than LDL in Statin-Treated Patients

Caitlin E. Cox

March 14, 2023

News Conference News ACC 2023

Treat to Target or With Intensity? Both Statin Tactics Cut MACE: LODESTAR

Michael O'Riordan

March 13, 2023

News Conference News ACC 2023

Tailored Alerts Up High-Intensity Statin Prescribing: PCDS Statin

Yael L. Maxwell

March 13, 2023

News Conference News ACC 2023

STREAM-2: Half-Dose Tenecteplase Safe, Effective in Older STEMI Patients

L.A. McKeown

March 10, 2023

News Conference News ACC 2023

Oral PCSK9 Inhibitor Reduces LDL Cholesterol in Phase IIb Study

Todd Neale

March 10, 2023

News Conference News ACC 2023

‘Causal AI’ May Help Guide Specific Actions to Reduce CVD Risk

Caitlin E. Cox

March 10, 2023

News Conference News ACC 2023

Short DAPT Noninferior to 1 Year After Ultrathin DES PCI: HOST-IDEA

Yael L. Maxwell

March 09, 2023

Advertisement

TEER or VAD/Transplant in the Advanced HF Patient With MR?

PCI’s Role for Patients With HFrEF and Extensive CAD: Experts Debate

What are the Strengths and Limitations of a Two-Phase (6-Month Intermediate Endpoints & 12-18 Month Mortality and Heart Failure Hospitalization) Trial Design

Small Improvements in Fitness Add Up to Big Mortality Gains, Study Finds

Second Recall in Less Than 2 Months for Cardiosave IABPs

SAFE-AAA Flags Ongoing EVAR Device Risk and Urges More Surveillance

Acute AF Can Recur: Manage and Monitor Long-term, Says AHA

Sugar Substitute Erythritol Linked to Cardiac Risk

Mediterranean Diet’s CV Benefits Extend to Women: Meta-analysis

Diabetic Patients in Middle East, Africa Overburdened by ASCVD

IMPLEMENT-HF: ‘Virtual’ Stewardship May Help Optimize GDMT in HFrEF

CRP More Predictive of Future Events Than LDL in Statin-Treated Patients

Treat to Target or With Intensity? Both Statin Tactics Cut MACE: LODESTAR

Tailored Alerts Up High-Intensity Statin Prescribing: PCDS Statin

STREAM-2: Half-Dose Tenecteplase Safe, Effective in Older STEMI Patients

Oral PCSK9 Inhibitor Reduces LDL Cholesterol in Phase IIb Study

‘Causal AI’ May Help Guide Specific Actions to Reduce CVD Risk

Short DAPT Noninferior to 1 Year After Ultrathin DES PCI: HOST-IDEA

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content